Career history of Daniel-Adriano Silva
Former positions of Daniel-Adriano Silva
| Companies | Position | Start | End |
|---|---|---|---|
| NEUROGENE INC. | Chief Tech/Sci/R&D Officer | 2003-11-30 | 2021-02-28 |
| Founder | 2003-11-30 | 2021-02-28 |
Training of Daniel-Adriano Silva
| Universidad Nacional Autónoma de México | Undergraduate Degree |
Statistics
International
| Mexico | 2 |
| United States | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Daniel-Adriano Silva
- Experience
